# Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy

> **NCT01941173** · NA · WITHDRAWN · sponsor: **City of Hope Medical Center**

## Conditions studied

- Recurrent Colon Cancer
- Recurrent Rectal Cancer
- Stage IVA Colon Cancer
- Stage IVA Rectal Cancer
- Stage IVB Colon Cancer
- Stage IVB Rectal Cancer

## Interventions

- **BIOLOGICAL:** ziv-aflibercept
- **DRUG:** leucovorin calcium
- **DRUG:** irinotecan hydrochloride
- **DRUG:** fluorouracil

## Key facts

- **NCT ID:** NCT01941173
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-01
- **Primary completion:** 2014-07
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of accrual
- **Last updated:** 2014-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01941173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01941173, "Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT01941173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*